Allergic To Centralization

research report

Hello,

After writing up a few interesting Italian names, I’m now turning to a promising Swedish serial acquirer that flies under the radar. Despite its low profile on Fintwit and online, I believe it has the potential to grow EBIT per share at an 18% CAGR over the medium term, in a predictable manner. That growth potential, along with its current 12x NTM EV/EBIT valuation, makes for an intriguing setup.

Without further ado, let’s dig in.